News Cereno Scientific AB

Equities

CRNO B

SE0008241558

Delayed Nasdaq Stockholm Other stock markets 07:00:19 23/05/2024 pm IST			5-day change	1st Jan Change
4.058 ^SEK	+8.85%		+13.54%	-11.30%

08:30am	Cereno Scientific AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
02/05	Cereno Scientific AB Announces Nomination Committee Appointments Ahead of Annual General Meeting 2025	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cereno Scientific publishes the interim report for Q1 2024 ( January 1-March 31)	12:01pm	AQ
Cereno Scientific AB Reports Earnings Results for the First Quarter Ended March 31, 2024	12:00pm	CI
Cereno Scientific presents at ABGSC Investor Days, May 23	17/05	AQ
Cereno Scientific to present preclinical data for drug candidate CS585 at the EHA 2024 Hybrid Congress	15/05	AQ
Cereno Scientific: Nomination committee appointed ahead of annual general meeting 2025	02/05	AQ
Cereno Scientific AB Announces Nomination Committee Appointments Ahead of Annual General Meeting 2025	02/05	CI
Report from Annual General Meeting 2024 of Cereno Scientific AB	16/04	AQ
Cereno Scientific AB Approves Election of New Directors	16/04	CI
Cereno Scientific Secures Patent Expansion in Canada for Hypertension Drug Candidate	11/04	MT
Cereno Scientific expands patent protection for epigenetic HDAC inhibitor CS1:s second patent family	11/04	AQ
Cereno Scientific Files Clinical Trial Application for Blood Cut Treatment	10/04	MT
Cereno Scientific submits Clinical Trial Application (CTA) for first-in-human Phase I study with novel epigenetic HDACi drug candidate CS014	10/04	AQ
Cereno Scientific AB Submits Clinical Trial Application for First-In-Human Phase I Study with Novel Epigenetic HDACi Drug Candidate CS014	10/04	CI
Cereno Scientific Receives Patent Expansion in Europe	09/04	MT
Cereno Scientific announces extended patent protection in Europe for CS585 program	09/04	AQ
Cereno Scientific releases Insights Video Season 3 Episode 9 with Dr. Björn Dahlöf, CSO, Cereno Scientific	03/04	AQ
Cereno Scientific participates at the ISHLT 44th Annual meeting and Scientific sessions to expand network and meet with investigators for the Phase II Study in PAH	28/03	AQ
Cereno Scientific releases Insights Video Season 3 Episode 8 with Björn Dahlöf, CSO, Cereno Scientific	27/03	AQ
Cereno Scientific publishes Annual Report for 2023	26/03	AQ
Cereno Scientific participates at the upcoming medical conference ACC.24 to further build presence in the Cardiology community	25/03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cereno Scientific AB

Equities

CRNO B

SE0008241558

Summary

Filters